Hospital Infection Therapeutic Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Hospital Infection Therapeutics are used for treating Hospital Acquired diseases which are nosocomial infections that could be acquired by the patient from another patient in the hospital, the surroundings and environment of the hospital or any other health care facility.
MARKET DYNAMICS
The Hospital Infection Therapeutic market is anticipated to grow in the forecast period owing to driving factors such as increasing number of hospital admitted patients, complacency among healthcare providers, growing antimicrobial resistance among certain strains of bacteria, poor infrastructure, understaffing and insufficient hospital equipment, overcrowding and lack of knowledge about blood transfusion safety measures and rising geriatric population. Nevertheless, strict regulatory requirement, high cost of treatment and lack of transparent reimbursement scenario is expected to hinder the market growth during the forecast period.
MARKET SCOPE
The "Global Hospital Infection Therapeutic Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hospital Infection Therapeutic market with detailed market segmentation by drug type, infections and geography. The global Hospital Infection Therapeutic market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Hospital Infection Therapeutic market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Hospital Infection Therapeutic market is segmented on the basis of Drug Type and Infections. Based on Drug Type the market is segmented into Antibacterial Drugs, Antiviral Drugs and Antifungal Drugs. Based on Infections the market is segmented into Hospital Acquired Pneumonia, Surgical Site Infections, Urinary Tract Infection, Gastrointestinal Disorders, Bloodstream Infections and Other Hospital Infections.
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Hospital Infection Therapeutic market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hospital Infection Therapeutic market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Hospital Infection Therapeutic market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hospital Infection Therapeutic market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Hospital Infection Therapeutic market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hospital Infection Therapeutic market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Hospital Infection Therapeutic market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hospital Infection Therapeutic market in these regions.
MARKET PLAYERSThe reports cover key developments in the Hospital Infection Therapeutic Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Hospital Infection Therapeutic Market are anticipated to lucrative growth opportunities in the future with the rising demand for Hospital Infection Therapeutic in the global market. Below mentioned is the list of few companies engaged in the Hospital Infection Therapeutic market.
The report also includes the profiles of key Hospital Infection Therapeutic market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Bayer Ag
- Johnson & Johnson Services Inc.
- Actavis Plc
- Sanofi
- Bristol Myers Squibb Company
- AstraZeneca Plc
- Pfizer Inc.
- Merck & Co, Inc.
- GlaxoSmithkline Plc
- Cubist Pharmaceuticals, Inc.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hospital Infection Therapeutic Market - By Drug Type
1.3.2 Hospital Infection Therapeutic Market - By Infections
1.3.3 Hospital Infection Therapeutic Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. HOSPITAL INFECTION THERAPEUTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HOSPITAL INFECTION THERAPEUTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. HOSPITAL INFECTION THERAPEUTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. HOSPITAL INFECTION THERAPEUTIC - GLOBAL MARKET OVERVIEW
6.2. HOSPITAL INFECTION THERAPEUTIC - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HOSPITAL INFECTION THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTIBACTERIAL DRUGS
7.3.1. Overview
7.3.2. Antibacterial Drugs Market Forecast and Analysis
7.4. ANTIVIRAL DRUGS
7.4.1. Overview
7.4.2. Antiviral Drugs Market Forecast and Analysis
7.5. ANTIFUNGAL DRUGS
7.5.1. Overview
7.5.2. Antifungal Drugs Market Forecast and Analysis
8. HOSPITAL INFECTION THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2028 - INFECTIONS
8.1. OVERVIEW
8.2. INFECTIONS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL ACQUIRED PNEUMONIA
8.3.1. Overview
8.3.2. Hospital Acquired Pneumonia Market Forecast and Analysis
8.4. SURGICAL SITE INFECTIONS
8.4.1. Overview
8.4.2. Surgical Site Infections Market Forecast and Analysis
8.5. URINARY TRACT INFECTION
8.5.1. Overview
8.5.2. Urinary Tract Infection Market Forecast and Analysis
8.6. GASTROINTESTINAL DISORDERS
8.6.1. Overview
8.6.2. Gastrointestinal Disorders Market Forecast and Analysis
8.7. BLOODSTREAM INFECTIONS
8.7.1. Overview
8.7.2. Bloodstream Infections Market Forecast and Analysis
8.8. OTHER HOSPITAL INFECTIONS.
8.8.1. Overview
8.8.2. Other Hospital Infections. Market Forecast and Analysis
9. HOSPITAL INFECTION THERAPEUTIC MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Hospital Infection Therapeutic Market Overview
9.1.2 North America Hospital Infection Therapeutic Market Forecasts and Analysis
9.1.3 North America Hospital Infection Therapeutic Market Forecasts and Analysis - By Drug Type
9.1.4 North America Hospital Infection Therapeutic Market Forecasts and Analysis - By Infections
9.1.5 North America Hospital Infection Therapeutic Market Forecasts and Analysis - By Countries
9.1.5.1 United States Hospital Infection Therapeutic Market
9.1.5.1.1 United States Hospital Infection Therapeutic Market by Drug Type
9.1.5.1.2 United States Hospital Infection Therapeutic Market by Infections
9.1.5.2 Canada Hospital Infection Therapeutic Market
9.1.5.2.1 Canada Hospital Infection Therapeutic Market by Drug Type
9.1.5.2.2 Canada Hospital Infection Therapeutic Market by Infections
9.1.5.3 Mexico Hospital Infection Therapeutic Market
9.1.5.3.1 Mexico Hospital Infection Therapeutic Market by Drug Type
9.1.5.3.2 Mexico Hospital Infection Therapeutic Market by Infections
9.1.5.4 US Hospital Infection Therapeutic Market
9.1.5.4.1 US Hospital Infection Therapeutic Market by Drug Type
9.1.5.4.2 US Hospital Infection Therapeutic Market by Infections
9.2. EUROPE
9.2.1 Europe Hospital Infection Therapeutic Market Overview
9.2.2 Europe Hospital Infection Therapeutic Market Forecasts and Analysis
9.2.3 Europe Hospital Infection Therapeutic Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Hospital Infection Therapeutic Market Forecasts and Analysis - By Infections
9.2.5 Europe Hospital Infection Therapeutic Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Hospital Infection Therapeutic Market
9.2.5.1.1 Germany Hospital Infection Therapeutic Market by Drug Type
9.2.5.1.2 Germany Hospital Infection Therapeutic Market by Infections
9.2.5.2 France Hospital Infection Therapeutic Market
9.2.5.2.1 France Hospital Infection Therapeutic Market by Drug Type
9.2.5.2.2 France Hospital Infection Therapeutic Market by Infections
9.2.5.3 Italy Hospital Infection Therapeutic Market
9.2.5.3.1 Italy Hospital Infection Therapeutic Market by Drug Type
9.2.5.3.2 Italy Hospital Infection Therapeutic Market by Infections
9.2.5.4 Spain Hospital Infection Therapeutic Market
9.2.5.4.1 Spain Hospital Infection Therapeutic Market by Drug Type
9.2.5.4.2 Spain Hospital Infection Therapeutic Market by Infections
9.2.5.5 United Kingdom Hospital Infection Therapeutic Market
9.2.5.5.1 United Kingdom Hospital Infection Therapeutic Market by Drug Type
9.2.5.5.2 United Kingdom Hospital Infection Therapeutic Market by Infections
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Hospital Infection Therapeutic Market Overview
9.3.2 Asia-Pacific Hospital Infection Therapeutic Market Forecasts and Analysis
9.3.3 Asia-Pacific Hospital Infection Therapeutic Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Hospital Infection Therapeutic Market Forecasts and Analysis - By Infections
9.3.5 Asia-Pacific Hospital Infection Therapeutic Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Hospital Infection Therapeutic Market
9.3.5.1.1 Australia Hospital Infection Therapeutic Market by Drug Type
9.3.5.1.2 Australia Hospital Infection Therapeutic Market by Infections
9.3.5.2 China Hospital Infection Therapeutic Market
9.3.5.2.1 China Hospital Infection Therapeutic Market by Drug Type
9.3.5.2.2 China Hospital Infection Therapeutic Market by Infections
9.3.5.3 India Hospital Infection Therapeutic Market
9.3.5.3.1 India Hospital Infection Therapeutic Market by Drug Type
9.3.5.3.2 India Hospital Infection Therapeutic Market by Infections
9.3.5.4 Japan Hospital Infection Therapeutic Market
9.3.5.4.1 Japan Hospital Infection Therapeutic Market by Drug Type
9.3.5.4.2 Japan Hospital Infection Therapeutic Market by Infections
9.3.5.5 South Korea Hospital Infection Therapeutic Market
9.3.5.5.1 South Korea Hospital Infection Therapeutic Market by Drug Type
9.3.5.5.2 South Korea Hospital Infection Therapeutic Market by Infections
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Hospital Infection Therapeutic Market Overview
9.4.2 Middle East and Africa Hospital Infection Therapeutic Market Forecasts and Analysis
9.4.3 Middle East and Africa Hospital Infection Therapeutic Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Hospital Infection Therapeutic Market Forecasts and Analysis - By Infections
9.4.5 Middle East and Africa Hospital Infection Therapeutic Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Hospital Infection Therapeutic Market
9.4.5.1.1 South Africa Hospital Infection Therapeutic Market by Drug Type
9.4.5.1.2 South Africa Hospital Infection Therapeutic Market by Infections
9.4.5.2 Saudi Arabia Hospital Infection Therapeutic Market
9.4.5.2.1 Saudi Arabia Hospital Infection Therapeutic Market by Drug Type
9.4.5.2.2 Saudi Arabia Hospital Infection Therapeutic Market by Infections
9.4.5.3 U.A.E Hospital Infection Therapeutic Market
9.4.5.3.1 U.A.E Hospital Infection Therapeutic Market by Drug Type
9.4.5.3.2 U.A.E Hospital Infection Therapeutic Market by Infections
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Hospital Infection Therapeutic Market Overview
9.5.2 South and Central America Hospital Infection Therapeutic Market Forecasts and Analysis
9.5.3 South and Central America Hospital Infection Therapeutic Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Hospital Infection Therapeutic Market Forecasts and Analysis - By Infections
9.5.5 South and Central America Hospital Infection Therapeutic Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Hospital Infection Therapeutic Market
9.5.5.1.1 Brazil Hospital Infection Therapeutic Market by Drug Type
9.5.5.1.2 Brazil Hospital Infection Therapeutic Market by Infections
9.5.5.2 Argentina Hospital Infection Therapeutic Market
9.5.5.2.1 Argentina Hospital Infection Therapeutic Market by Drug Type
9.5.5.2.2 Argentina Hospital Infection Therapeutic Market by Infections
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. HOSPITAL INFECTION THERAPEUTIC MARKET, KEY COMPANY PROFILES
11.1. BAYER AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. JOHNSON & JOHNSON SERVICES INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ACTAVIS PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SANOFI
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BRISTOL MYERS SQUIBB COMPANY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ASTRAZENECA PLC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MERCK & CO, INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. GLAXOSMITHKLINE PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CUBIST PHARMACEUTICALS, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
- Bayer Ag
- Johnson & Johnson Services Inc.
- Actavis Plc
- Sanofi
- Bristol Myers Squibb Company
- AstraZeneca Plc
- Pfizer Inc.
- Merck & Co, Inc.
- GlaxoSmithkline Plc
- Cubist Pharmaceuticals, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For